Prof. Anne Marie Healy

Professor Anne Marie Healy

Professor of Pharmaceutics and Pharmaceutical Technology, Head of School, School of Pharmacy
Role in SSPC: Strand 3 Co-Lead, PI
Researcher Profile

Trinity College Dublin
  • B.Sc. (Pharm), School of Pharmacy, Trinity College Dublin, 1989
  • Ph.D, Pharmaceutics, Trinity College Dublin, 1995
Research Interests: 
  • Mechanisms of drug release from solid dosage forms. Computer modelling of pharmaceutical systems. Mechanisms of dissolution of multicomponent systems. Processing of pharmaceuticals by spray drying. Layered drug delivery systems.

Short Bio
Professor Anne Marie Healy is a Professor in Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (TCD) and is currently Head of School. She was awarded a Special Visiting Research Fellowship by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil) in 2014 to further her collaborative research with the Faculty of Pharmacy of the Federal University of Rio de Janeiro. This research focuses on single and combination dosage forms and on the re-formulation of “old” drugs to improve treatment by either the pulmonary or oral route.
Professor Healy’s research interests include the mechanisms of drug release from solid dose forms, computer modelling of pharmaceutical systems, mechanisms of dissolution of multicomponent systems, processing of pharmaceuticals by spray drying and layered drug delivery systems. 
In 2016, Professor Healy was awarded €600,000 as part of a larger collaboration work €8.8m in funding from the National Institute of Health (NIH). The project aims to develop a first-of-its-kind inhaler for the treatment of lung diseases, such as cystic fibrosis.  This project is coordinated by Professor John Fahy, University of California San Francisco.

Professor Healy has authored more than 90 peer-reviewed publications.  Here most recent journal article, Rolón M, Serrano DR, Lalatsa A, de Pablo E, Torrado JJ, Ballesteros MP, Healy AM, Vega, C, Corone C, Bolás-Fernández F, Dea-Ayuela MA, Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections, Molecular Pharmaceutics, 14, (4), 2017, p1095-1106 Journal Article, 2017 can be accessed here.

Download CV
Selected Publications